Startups
We restore endothelial cell function
About Pantherna
Pantherna Therapeutics is a privately-held biopharmaceutical company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is
About Pantherna
Pantherna Therapeutics is a privately-held biopharmaceutical company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is
Overview
Location
Czechia, Prague
Total raised
$8.51M
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jul 3, 2019 | Seed round | $3.95M |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 3, 2019 | Pantherna Therapeutics Secures €3.5M in Seed Financing | Pantherna Therapeutics, a Hennigsdorf, Germany-based life science startup, secured €3.5m in seed financing. Backers included High-Tech Gründerfonds (HTGF), European Business Angel Prof. Detlev Riesner as well as the European Investment Fund... |
| “First-in-Class“ mRNA-therapeutics for vascular diseases: Pantherna Therapeutics receives 7-digit investment | ARDS is a life-threatening condition characterized by widespread and excessive inflammation in lung tissue. This inflammation induces a disease process characterized by a pathological cascade of reactions. Currently, ARDS has a mortality ra... |
Reviews 0
FAQ about Pantherna
How much funding has Pantherna raised?
Pantherna has raised $8.51M in total across 2 funding rounds.
What funding rounds has Pantherna raised?
Parsers VC lists 2 funding rounds of Pantherna, among them a seed round of $3.95M on Jul 3, 2019.
What has the press written about Pantherna?
Parsers VC has collected 3 articles mentioning Pantherna, among them “Pantherna Therapeutics Secures €3.5M in Seed Financing” (Jul 3, 2019) and ““First-in-Class“ mRNA-therapeutics for vascular diseases: Pantherna Therapeutics receives 7-digit investment”.
Is Pantherna still active?
Yes, Pantherna is active; its latest activity on Parsers VC dates from Jan 19, 2022.